Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer.

Bei, Yi; Bramé, Luca; Kirchner, Marieluise; Fritsche-Guenther, Raphaela; Kunz, Severine; Bhattacharya, Animesh; Rusu, Mara-Camelia; Gürgen, Dennis; Dubios, Frank P B; Köppke, Julia K C; Proba, Jutta; Wittstruck, Nadine; Sidorova, Olga Alexandra; Chamorro González, Rocío; Dorado Garcia, Heathcliff; Brückner, Lotte; Xu, Robin; Giurgiu, Madalina; Rodriguez-Fos, Elias; Yu, Qinghao; Spanjaard, Bastiaan; Koche, Richard P; Schmitt, Clemens A; Schulte, Johannes H; Eggert, Angelika; Haase, Kerstin; Kirwan, Jennifer; Hagemann, Anja I H; Mertins, Philipp; Dörr, Jan R; Henssen, Anton G

Bei, Yi; Bramé, Luca; Kirchner, Marieluise; Fritsche-Guenther, Raphaela; Kunz, Severine; Bhattacharya, Animesh; Rusu, Mara-Camelia; Gürgen, Dennis; Dubios, Frank P B; Köppke, Julia K C; Proba, Jutta; Wittstruck, Nadine; Sidorova, Olga Alexandra; Chamorro González, Rocío; Dorado Garcia, Heathcliff; Brückner, Lotte; Xu, Robin; Giurgiu, Madalina; Rodriguez-Fos, Elias; Yu, Qinghao; Spanjaard, Bastiaan; Koche, Richard P; Schmitt, Clemens A; Schulte, Johannes H; Eggert, Angelika; Haase, Kerstin; Kirwan, Jennifer; Hagemann, Anja I H; Mertins, Philipp; Dörr, Jan R; Henssen, Anton G.

Affiliation

Bei Y; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Bramé L; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Kirchner M; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Fritsche-Guenther R; Core Unit Proteomics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Kunz S; Core Unit Metabolomics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
Bhattacharya A; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Technology Platform Electron Microscopy, Berlin, Germany.
Rusu MC; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Gürgen D; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Technology Platform Electron Microscopy, Berlin, Germany.
Dubios FPB; Experimental Pharmacology and Oncology (EPO), Berlin, Germany.
Köppke JKC; Institute of pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Proba J; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Wittstruck N; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sidorova OA; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Chamorro González R; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Dorado Garcia H; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Brückner L; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Xu R; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Giurgiu M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Technology Platform Electron Microscopy, Berlin, Germany.
Rodriguez-Fos E; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Yu Q; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Spanjaard B; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Koche RP; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Schmitt CA; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Schulte JH; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York.
Eggert A; Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Haase K; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Kirwan J; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Hagemann AIH; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Mertins P; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Dörr JR; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Henssen AG; Core Unit Metabolomics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.

Cancer Discov ; 14(3): 492-507, 2024 Mar 01.

Article de En | MEDLINE | ID: mdl-38197697

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oncogènes / Tumeurs Limites: Humans Langue: En Journal: Cancer Discov Année: 2024 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google